Published in Cancer Immunol Immunother on June 01, 1996
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer. Oncologist (2011) 1.21
Immunological monitoring of anticancer vaccines in clinical trials. Oncoimmunology (2013) 0.95
Mucins in ovarian cancer diagnosis and therapy. J Ovarian Res (2009) 0.94
Humoral response to a viral glycan correlates with survival on PROSTVAC-VF. Proc Natl Acad Sci U S A (2014) 0.91
Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality. Clin Lung Cancer (2010) 0.88
Recent advances in the development of breast cancer vaccines. Breast Cancer (Dove Med Press) (2014) 0.85
Sialyl-tn in cancer: (how) did we miss the target? Biomolecules (2012) 0.84
The Role of Sialyl-Tn in Cancer. Int J Mol Sci (2016) 0.83
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients. BMC Cancer (2012) 0.82
Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies. Cancer J (2013) 0.82
Lung cancer vaccines. Cancer J (2011) 0.82
Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas. Vaccine (2007) 0.81
Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis. Exp Ther Med (2012) 0.79
Glycosylations versus conformational preferences of cancer associated mucin core. Glycoconj J (2000) 0.78
Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract (2011) 3.77
Distribution of T cell subsets in human lymph nodes. J Exp Med (1981) 3.64
Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med (1980) 3.41
Connective tissue ossification presenting in the skin. Arch Dermatol (1966) 2.98
The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia (2006) 2.21
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet (2005) 2.03
Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin Exp Immunol (1982) 2.00
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med (1998) 1.91
Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol (1989) 1.91
Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood (1992) 1.88
Central venous catheter-related complications in newborns and infants: a 587-case survey. J Pediatr Surg (1991) 1.83
A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol (2001) 1.80
High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol (1999) 1.78
Murine T-cell clones specific for chicken erythrocyte alloantigens. Cell Immunol (1986) 1.77
Monoclonal antibodies reactive with hairy cell leukemia. Blood (1989) 1.75
Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol (1987) 1.71
In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood (1982) 1.71
Mechanism of photosystem II photoinactivation and D1 protein degradation at low light: the role of back electron flow. Proc Natl Acad Sci U S A (1997) 1.71
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene (2006) 1.69
Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation (1987) 1.65
Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer (1990) 1.65
Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol (1989) 1.59
Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells. Br J Haematol (1990) 1.55
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood (1990) 1.53
Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med (1991) 1.50
The New York State universal newborn hearing screening demonstration project: outpatient outcome measures. Ear Hear (2000) 1.46
bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis. Mod Pathol (1998) 1.43
The effects of circulating antigen on the pharmacokinetics and radioimmunoscintigraphic properties of 99m Tc labelled monoclonal antibodies in cancer patients. J Pharm Pharm Sci (2000) 1.43
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
DNA analysis (ploidy) of molar pregnancies with image analysis on paraffin tissue sections. Am J Clin Pathol (1993) 1.40
Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun (1993) 1.39
Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling. Proc Natl Acad Sci U S A (1999) 1.39
The New York State universal newborn hearing screening demonstration project: ages of hearing loss identification, hearing aid fitting, and enrollment in early intervention. Ear Hear (2000) 1.38
[Freiburg Questionnaire of physical activity--development, evaluation and application]. Soz Praventivmed (1999) 1.38
The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem (1980) 1.37
Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood (1993) 1.29
Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology (1979) 1.28
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res (1985) 1.28
Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. Eur J Immunol (1989) 1.27
The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res (1996) 1.24
Image Analysis of Geo-Induced Inhibition, Compression, and Promotion of Growth in an Inverted Helianthus annuus L. Seedling. Plant Physiol (1984) 1.23
Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest (1986) 1.23
Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. Cancer Res (1998) 1.20
The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections. Int J Cancer (1979) 1.16
New macrolides and furan carboxylic acid derivative from the sponge-derived fungus Cladosporium herbarum. J Nat Prod (2001) 1.16
Different expressions of trypsin and chymotrypsin in relation to growth in Atlantic salmon (Salmo salar L.). Fish Physiol Biochem (2006) 1.15
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol Immunother (1993) 1.15
Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers. J Natl Cancer Inst (1987) 1.15
Trisomy 21 (Down syndrome): studying nondisjunction and meiotic recombination by using cytogenetic and molecular polymorphisms that span chromosome 21. Am J Hum Genet (1988) 1.14
Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide. J Immunother Emphasis Tumor Immunol (1996) 1.13
Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology (2001) 1.13
Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes Relat Metab Disord (2004) 1.12
Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Ann Oncol (2002) 1.12
Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res (1985) 1.11
Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul (1991) 1.10
A novel physiological function for platelet-derived growth factor-BB in rat dermis. J Physiol (1996) 1.10
Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol (1979) 1.09
Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation (2000) 1.09
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol (1998) 1.09
Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J Biol Chem (1995) 1.09
The race-specific elicitor AVR9 of the tomato pathogen Cladosporium fulvum: a cystine knot protein. Sequence-specific 1H NMR assignments, secondary structure and global fold of the protein. FEBS Lett (1997) 1.09
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res (1995) 1.09
Cardiovascular, metabolic, and hormonal parameters in professional tennis players. Med Sci Sports Exerc (2001) 1.08
Nomenclature for chicken major histocompatibility (B) complex. Immunogenetics (1982) 1.08
[Sport and the digestive system]. Dtsch Med Wochenschr (2007) 1.08
Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res (1988) 1.08
Serial analysis of gene expression: rapid RT-PCR analysis of unknown SAGE tags. Nucleic Acids Res (1999) 1.08
A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial. BJOG (2010) 1.07
Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells. Cancer Immunol Immunother (1999) 1.06
Cohesive sites and helper phage function of P2, lambda, and 186 DNA's. Proc Natl Acad Sci U S A (1968) 1.06
Markers of inflammation and myofibrillar proteins following eccentric exercise in humans. Eur J Appl Physiol (2001) 1.06
HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Tissue Antigens (2008) 1.06
TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol (2001) 1.06
Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease. Am J Pathol (1985) 1.06
Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol (1989) 1.06
B lymphocyte differentiation in the rat: production and characterization of monoclonal antibodies to B lineage-associated antigens. Eur J Immunol (1987) 1.06
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol (2002) 1.05
European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs -- a GALEN initiative. Allergy (2006) 1.05
Sonography, CT, and MR imaging: a prospective comparison of neonates with suspected intracranial ischemia and hemorrhage. AJNR Am J Neuroradiol (2000) 1.04
Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer (1985) 1.04
Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain. J Biol Chem (2001) 1.04
Long-term follow up after sex reassignment surgery. Scand J Plast Reconstr Surg Hand Surg (1997) 1.04
Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today (1997) 1.03
Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine. J Immunother Emphasis Tumor Immunol (1996) 1.03
Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. Clin Exp Immunol (1984) 1.03
Fournier's gangrene complicating aggressive therapy for hematologic malignancy. Cancer (1986) 1.03
Reactivity of presumed anti-natural killer cell antibody Leu 7 with intrafollicular T lymphocytes. Clin Exp Immunol (1983) 1.03
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer. Br J Cancer (1996) 1.03
New York State universal newborn hearing screening demonstration project: effects of screening protocol on inpatient outcome measures. Ear Hear (2000) 1.01
Intracranial malignant lymphomas. A morphologic and immunocytologic study of twenty cases. Acta Neuropathol (1978) 1.01
Purification and characterization of cytochrome P-450meg. J Biol Chem (1979) 1.01
Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res (1990) 1.01
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int J Cancer (1998) 1.01
Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol (1993) 1.01